Search results
Results from the WOW.Com Content Network
Molecular neuropharmacology involves the study of neurons and their neurochemical interactions, and receptors on neurons, with the goal of developing new drugs that will treat neurological disorders such as pain, neurodegenerative diseases, and psychological disorders (also known in this case as neuropsychopharmacology).
The International Journal of Neuropsychopharmacology is a peer-reviewed scientific journal published by Oxford University Press.It is an official journal of the Collegium Internationale Neuro-Psychopharmacologicum (CINP) (International College of Neuro-Psychopharmacology) and covers basic and clinical topics in neuropharmacology and psychopharmacology.
The most basic and fundamental neurological phenomena in neuropharmacology is the binding of a drug or neurologically active substance to a cellular target. One assay to determine the extent at which a ligand binds to its receptor is the radioligand binding assay (RBA), in which specific binding of a radioactively-labeled ligand is denoted by ...
Download QR code; Print/export Download as PDF; Printable version; In other projects Wikimedia Commons; Wikidata item; ... Pages in category "Neuropharmacology"
The Clinical Neuropharmacology is a peer-reviewed bimonthly journal publishes original articles, brief reports, reviews devoted to the pharmacology of the nervous system in its broadest sense. According to the Journal Citation Reports , the journal has a 2014 impact factor of 2.009 . [ 1 ]
Download QR code; Print/export Download as PDF; Printable version; In other projects ... It was established in 1962 as the International Journal of Neuropharmacology ...
Download as PDF; Printable version; ... Neuropharmacology is the study of how drugs affect cellular function in the nervous system. ... Neuroscience of free will;
Stahl was born in Wauseon, Ohio and raised in Bryan, Ohio. In 1973, he completed his B.S. degree from Northwestern University and received his M.D. there in 1975. In 1976, he received his Ph.D. in Neuropharmacology from the University of Chicago.